Viewing Study NCT04520451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-25 @ 9:48 PM
Study NCT ID: NCT04520451
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2020-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
Sponsor: Principia Biopharma, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module